Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
Recruiting
N/A
Interventional Study
Cervical Cancer
CIN2
CIN3
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 25 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 300 (estimated)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women.
Cervical cancer occurs when women are infected with the human papillomavirus (HPV), which can cause changes in the cells that lead to cervical precancer and, eventually, cervical cancer if untreated. However, urine HPV testing has not been well val…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
1. Confirmed HIV-1 infection
2. Age 25 years and older.
3. Be willing and able to provide written informed consent.
Exclusion Criteria:
1. Pregnant or intend to become pr…
Contacts